Andrea Watson, RN, BSN, OCN
Saint Luke's Koontz Center for Advanced Breast Cancer, Kansas City, MOAuthored Items
November 2017 Vol 8, No 11
Endocrine therapy is recommended for patients with hormone receptor–positive (HR+) advanced and metastatic breast cancer without visceral crisis (symptomatic visceral disease).
Last modified: June 5, 2018